Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening?
Towart R, Linders JT, Hermans AN, Rohrbacher J, van der Linde HJ, Ercken M, Cik M, Roevens P, Teisman A, Gallacher DJ.
Towart R, et al. Among authors: hermans an.
J Pharmacol Toxicol Methods. 2009 Jul-Aug;60(1):1-10. doi: 10.1016/j.vascn.2009.04.197. Epub 2009 May 9.
J Pharmacol Toxicol Methods. 2009.
PMID: 19439185
Review.
We have exploited this molecule to develop a ligand binding assay to detect I(Ks) blockade at an earlier stage in drug discovery, and note that several other laboratories developing new drugs have also developed higher throughput screens to detect I(Ks) blockade (e.g., [Tr …
We have exploited this molecule to develop a ligand binding assay to detect I(Ks) blockade at an earlier stage in drug discovery, and …